DermaSilk Clinical Trials, 2

The therapeutic effects of DermaSilk have been extensively studied by clinicians throughout Europe and their findings published in "peer reviewed" academic medical journals. This means that the results demonstrated in the trials have been independently assessed as accurate by other doctors. The abstracts below give a brief description of the studies undertaken and the results obtained. No other product of this type has gone through such exhaustive tests to validate its effectiveness. DermaSilk continues to be researched in a wide range of medical conditions and future publications will be added when appropriate.

Clinical Effectiveness of a Silk Fabric in the Treatment of Atopic Dermatitis

Ricci, G and colleagues from Bologna University Hospital, Italy.
Published in British Journal of Dermatology. 2004. Issue 150. Pages 127 - 131

Objective

The purpose of this study was to evaluate the effectiveness of DermaSilk in the treatment of young children affected by atopic dermatitis at the time of examination.

Method

Forty six children, aged between 4 months and 10 years old with atopic dermatitis were recruited and randomised to DermaSilk (31 patients) or cotton clothing (15 patients) to be worn continuously for a week. The only other medicines prescribed were topical moisturisers. No steroid creams or topical antibiotics were prescribed.

The severity of the eczema was measured by the SCORAD index, a scientific way of measuring a mixture of physical and social effects that atopic dermatitis has on patients. The doctors measuring these scores were not aware which garments the patients were using.

Results

At the end of the study the SCORAD index of the DermaSilk group had significantly decreased from 47 to 30 whilst the cotton wearing group had moved from 47 to 46.

83% of children using the DermaSilk had shown an improvement in their overall condition, whereas none of the cotton wearing children had shown any improvement.

Areas of eczema which were present on the DermaSilk clothed children but which had not been covered by DermaSilk were also examined as a control. They did not show any significant improvement over the week suggesting that it was, indeed the covering of the eczema with DermaSilk that was having the beneficial effect.

The authors concluded that DermaSilk appeared to significantly improve the condition of eczema lesions and that the parents of these children also reported a reduction in itching and scratching.

DermaSilk appears to have a rapid effect on the symptoms of atopic dermatitis in children, showing a positive effect in only 7 days in over 80% of children and may represent a useful tool in the management of the disease.           

        

Conclusion

The authors concluded that DermaSilk appeared to significantly improve the condition of eczema lesions and that the parents of these children also reported a reduction in itching and scratching.

DermaSilk appears to have a rapid effect on the symptoms of atopic dermatitis in children, showing a positive effect in only 7 days in over 80% of children and may represent a useful tool in the management of the disease.